Table 4 Cancer Detection Rate of the Targeted Biopsy in relation to an axial and sagittal image fusion
Group B n = 89 | Overall CDR in TB (sTB + aTB) | CDR in aTB | CDR in sTB | Additional PCa detected only by sTB* | Additional GS ≥7 in sTB# |
|---|---|---|---|---|---|
Overall | 68 (76%) | 59 (66%) | 50 (56%) | 9 (13%) | 10 (19%) |
PI-RADS | |||||
3 (n = 8) | 2 (25%) | 2 (25%) | 2 (25%) | 0 | 0 |
4 (n = 43) | 32 (74%) | 30 (70%) | 19 (44%) | 2 (5%) | 4 (9%) |
5 (n = 38) | 34 (90%) | 27 (71%) | 29 (76%) | 7 (18%) | 6 (16%) |
Maximum diameter of lesion | |||||
1–10 (n = 27) | 18 (67%) | 15 (56%) | 10 (37%) | 3 (11%) | 3 (11%) |
11–20 (n = 50) | 38 (76%) | 33 (66%) | 29 (58%) | 5 (10%) | 5 (10%) |
>20 (n = 12) | 12 (100%) | 11 (92%) | 11 (92%) | 1 (8%) | 2 (17%) |
Localization of lesion | |||||
Apex (n = 35) | 26 (74%) | 23 (66%) | 19 (54%) | 3 (9%) | 3 (9%) |
Midgland (n = 32) | 23 (72%) | 18 (56%) | 15 (47%) | 5 (16%) | 5 (16%) |
Base (n = 22) | 19 (86%) | 18 (82%) | 16 (73%) | 1 (5%) | 2 (9%) |
Anterior (n = 28) | 26 (93%) | 22 (79%) | 22 (79%) | 4 (14%) | 5 (18%) |